逃避(道德)
免疫疗法
免疫系统
外体
机制(生物学)
免疫逃逸
癌症研究
CD63
免疫学
CD81号
微泡
生物
医学
小RNA
计算生物学
下调和上调
信号转导
免疫监视
生物信息学
转录组
作者
Jian Zhang,Ying Gu,Fangchao Zhao,Yong Chen,Yuqing Xia,Dekang Gao,Qiang Yuan,Xuming Bai
出处
期刊:Neoplasia
[Elsevier BV]
日期:2026-02-11
卷期号:73: 101280-101280
被引量:9
标识
DOI:10.1016/j.neo.2026.101280
摘要
BACKGROUND AND PURPOSE: Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths globally due to late diagnosis and resistance to therapies, including immune checkpoint blockade (ICB). Tumor-derived exosomes carrying programmed death-ligand 1 (PD-L1) have emerged as key mediators of immune evasion by binding PD-1 on T cells, thereby inducing T cell exhaustion and systemic immunosuppression. This study investigated whether Annexin A2 (ANXA2) modulates exosomal PD-L1 expression in HCC cells to inhibit T-cell function and promote immune escape. RESULTS: Bioinformatic analyses (TIMER2.0, TCGA) showed ANXA2 upregulation in HCC, correlating with fewer CD8⁺ T cells and poor survival. ANXA2 knockout (KO) in Hepa1-6 cells reduced exosome secretion and exosomal PD-L1, confirmed by EM, nanoparticle tracking, and WB. Exosomes from controls suppressed CD8⁺ T cell activation (reducing CD69, IL-2, IFN-γ, TNF-α), while KO exosomes did not. ANXA2 KO tumors grew slower in immunocompetent C57BL/6 J mice but not in immunodeficient BALB/c Nude mice, highlighting immune dependence. ANXA2 depletion reduced CD63 protein stability without affecting mRNA. CD63 re-expression in KO cells restored exosomal PD-L1, indicating ANXA2 maintains CD63 stability for PD-L1 exosomal incorporation. Transcriptomic and pharmacologic evidence further supported a role for lysosome-associated turnover in CD63 loss upon ANXA2 depletion. CONCLUSIONS: ANXA2 drives HCC immune evasion by upregulating exosomal PD-L1 via CD63 stabilization, offering a novel target to enhance ICB efficacy. This work highlights a tumor-specific exosome regulation mechanism, with potential implications for immunotherapy across exosome-dependent cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI